Evidence map›Paper›PMID 32090101›Full record

ArticleBioMed research international2020

Detection of

Mingliang Chu, Yanqiu Zhu, Jianjun Hu, Zhuxue Zhang, Meng Luo, Xiaobo Ma

Abstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mingliang ChuDepartment of Clinical Laboratory, First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang 550001, China.ORCID https://orcid.org/0000-0003-0559-8921
Yanqiu ZhuDepartment of Clinical Laboratory, First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang 550001, China.ORCID https://orcid.org/0000-0002-6258-4756
Jianjun HuDepartment of Pathology, Guizhou Provincial People's Hospital, Guiyang 550002, China.ORCID https://orcid.org/0000-0003-2018-0267
Zhuxue ZhangDepartment of Pathology, Guizhou Provincial People's Hospital, Guiyang 550002, China.ORCID https://orcid.org/0000-0001-6899-7095
Meng LuoDepartment of Thoracic Surgery, Guizhou Provincial People's Hospital, Guiyang 550002, China.
Xiaobo MaDepartment of Surgery-Transplant, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID https://orcid.org/0000-0003-2620-2033

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to evaluate the feasibility of measuring

Indexed as

Gene RearrangementAnaplastic Lymphoma KinaseCell-Free Nucleic AcidsFemaleHumansLung NeoplasmsMaleMiddle AgedPleural Effusion, MalignantALK protein, humanAnaplastic Lymphoma KinaseCell-Free Nucleic Acids

Identifiers

PMID32090101
PMCPMC6996684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.